NO138905B - PROCEDURES FOR THE PREPARATION OF 2- (6-CARBALCOXYHEXYL) -4 (R) -HYDROXYCYCLOPENT-2 ENONES - Google Patents

PROCEDURES FOR THE PREPARATION OF 2- (6-CARBALCOXYHEXYL) -4 (R) -HYDROXYCYCLOPENT-2 ENONES Download PDF

Info

Publication number
NO138905B
NO138905B NO4495/73A NO449573A NO138905B NO 138905 B NO138905 B NO 138905B NO 4495/73 A NO4495/73 A NO 4495/73A NO 449573 A NO449573 A NO 449573A NO 138905 B NO138905 B NO 138905B
Authority
NO
Norway
Prior art keywords
enol
ether
ester
substituted
solution
Prior art date
Application number
NO4495/73A
Other languages
Norwegian (no)
Other versions
NO138905C (en
Inventor
Charles John Sih
James Brian Heather
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of NO138905B publication Critical patent/NO138905B/en
Publication of NO138905C publication Critical patent/NO138905C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

Foreliggende oppfinnelse angår en fremgangsmåte ved fremstilling av 2-(6-car"balkoxyhexyl)-4 (R) -hydroxy-cyclopent-2-en-oner som er nøkkelforbindelser ved fremstilling av prostaglandiner eller prostaglandinlignende forbindelser. The present invention relates to a method for the production of 2-(6-carboxyhexyl)-4 (R)-hydroxy-cyclopent-2-en-ones which are key compounds in the production of prostaglandins or prostaglandin-like compounds.

Spesielt angår oppfinnelsen fremgangsmåte ved fremstilling av 2-(6-carbomethoxyhexyl)-4(R)-hydroxy-2-cyclopenten-l-on, In particular, the invention relates to a process for the production of 2-(6-carbomethoxyhexyl)-4(R)-hydroxy-2-cyclopenten-1-one,

en forbindelse som er en nøkkelforbindelse ved fremstilling av prostaglandiner. a compound that is a key compound in the production of prostaglandins.

Symbolet R som anvendt her angir den stereokjemiske konfigurasjon til en forbindelse som definert i Cahn-Ingold-Prelog nomenclatursystemet. The symbol R as used herein denotes the stereochemical configuration of a compound as defined in the Cahn-Ingold-Prelog nomenclature system.

Prostaglandinene som er cycliske, oxygenerte C2Q-fettsy-rer basert på prostansyreskjelettet, er antatt å spille en viktig rolle som terapeutiske midler på grunn av det store antall fysio-logiske responser de fremkaller i det cardiovaskulære system, i det sentrale og perifere nervesystem, i forplantningssystemet, det endocrine-, renale- og gastrointestinale system ved administrering til dyr innbefattet mennesket. Forrådet av disse materialer er for tiden meget begrenset, og de foreslåtte metoder for fremstilling av disse medfører bruk av tidkrevende spaltningsmetoder for å oppnå de ønskede optisk aktive forbindelser. The prostaglandins, which are cyclic, oxygenated C2Q fatty acids based on the prostanic acid skeleton, are believed to play an important role as therapeutic agents due to the large number of physiological responses they elicit in the cardiovascular system, in the central and peripheral nervous system, in the reproductive system, the endocrine, renal and gastrointestinal system when administered to animals including humans. The supply of these materials is currently very limited, and the proposed methods for producing them involve the use of time-consuming cleavage methods to obtain the desired optically active compounds.

Målet med denne oppfinnelse er å tilveiebringe en fremgangsmåte ved fremstilling av kirale forbindelser som er nøkkel-forbindelser ved fremstilling av prostaglandiner eller prostaglandinlignende forbindelser. The aim of this invention is to provide a method for the production of chiral compounds which are key compounds in the production of prostaglandins or prostaglandin-like compounds.

Oppfinnelsen angår således en fremgangsmåte ved fremstilling av 2-(6-carbalkoxyhexyl)-4(R)-hydroxy-cyclopent-2-enon av formelen The invention thus relates to a process for the production of 2-(6-carbalkoxyhexyl)-4(R)-hydroxy-cyclopent-2-enone of the formula

hvori R er en alkylgruppe med 1-2 carbonatomer, hvilken fremgangsmåte er kjennetegnet ved at a) et 2-(6-carbalkoxyhexyl)-4(R)-hydroxycyclopentan-1,3-dion av formelen: in which R is an alkyl group with 1-2 carbon atoms, which method is characterized by a) a 2-(6-carbalkoxyhexyl)-4(R)-hydroxycyclopentane-1,3-dione of the formula:

omsettes med et alkyliodid av formelen: is reacted with an alkyl iodide of the formula:

R'I RIDE

hvori R' er en isoamyl, isopropyl, isobutyl eller pivalylgruppe, under dannelse av en C-l og en C-3 enolether av formlene: wherein R' is an isoamyl, isopropyl, isobutyl or pivalyl group, forming a C-1 and a C-3 enol ether of the formulas:

eller med benzoylklorid under dannelse av en C-l og C-3 enolester av formlene: or with benzoyl chloride to form a C-1 and C-3 enol ester of the formulas:

hvor R" er fenyl, where R" is phenyl,

b) C-l enoletheren henholdsvis esteren separeres fra C-3 enoletheren- eller esteren, c) den fremstillede C-l substituerte enolester eller ether reduseres, og d) 2-(6-carbalkoxyhexyl)-4(R)-hydroxycyclopent-2-enon utvinnes fra reaksjonsblandingen. b) the C-1 enol ether or ester is separated from the C-3 enol ether or ester, c) the produced C-1 substituted enol ester or ether is reduced, and d) 2-(6-carbalkoxyhexyl)-4(R)-hydroxycyclopent-2-enone is recovered from the reaction mixture.

Tidligere har R. Pappo et al. (Annals of the New York Academy of Sciences, Vol. 180, s. 64 (1971)) vist følgende metode for fremstilling av methylenoletheren fra 2-(6<1->carbomethoxyhexyl)-4-hydroxy-cyclopenten-l,3-dion: Previously, R. Pappo et al. (Annals of the New York Academy of Sciences, Vol. 180, p. 64 (1971)) showed the following method for the preparation of methyleneol ether from 2-(6<1->carbomethoxyhexyl)-4-hydroxy-cyclopentene-1,3- Dion:

Denne prosedyre ble utført ved å koke hydroxydionesteren (A) under tilbakeløp med dimethoxypropan under sure betingelser under dannelse av de to angitte isomere enolestere (B og C). This procedure was carried out by refluxing the hydroxydionester (A) with dimethoxypropane under acidic conditions to form the two indicated isomeric enol esters (B and C).

Ulempene ved den av Pappo et al. beskrevne fremgangsmåte er: (1) den gir bare ca. 40 % av den ønskede C-l enolether (C), og (2) det asymmetriske senter ved C-4 ødelegges. The disadvantages of the one by Pappo et al. described procedure is: (1) it only gives approx. 40% of the desired C-1 enol ether (C), and (2) the asymmetric center at C-4 is destroyed.

Den siste ulempe er meget alvorlig ved prostaglandinfrem-stilling under anvendelse av 1,4-addisjonsreaksjoner, da stereokjemien til prostansyreskjelettet (C-8 og C-12-stillingene i prostaglandinene) dikteres av stereokjemien ved C-4. The last disadvantage is very serious in prostaglandin preparation using 1,4-addition reactions, as the stereochemistry of the prostanic acid skeleton (the C-8 and C-12 positions in the prostaglandins) is dictated by the stereochemistry at C-4.

Fremgangsmåten ifølge oppfinnelsen medfører ikke de ulem-per som Pappo et al. prosessen er beheftet med. Det viktigste er at fremgangsmåten ifølge oppfinnelsen tillater at det asymmetriske senter ved C-4 bibeholdes slik at det dannede 2-substituert-4-hydr-oxy-2-cyclopenten-l-on er kiral, et vesentlig trekk for hvordan prostaglandinene skal fremstilles. I tillegg aktiverer fremgangsmåten ifølge oppfinnelsen preferentielt acy-lering eller alkylering av oxygenatomet ved C-l stillingen i molekylet den molekylære konfigurasjon som er._ønsket for den etterfølgende reduksjon til den ønskede forbindelse, nemlig 2-(6-carbalkoxvhexyl)-4(R)-hydr-oxy-cyclopent-2-enon. The method according to the invention does not entail the disadvantages that Pappo et al. the process is fraught with. The most important thing is that the method according to the invention allows the asymmetric center at C-4 to be retained so that the formed 2-substituted-4-hydroxy-2-cyclopenten-1-one is chiral, an essential feature for how the prostaglandins are to be produced. In addition, the method according to the invention preferentially activates acylation or alkylation of the oxygen atom at the C-1 position in the molecule the molecular configuration that is desired for the subsequent reduction to the desired compound, namely 2-(6-carbalcoxyl)-4(R)-hydr -oxy-cyclopent-2-enone.

Selvom man ikke vil bindes til teoretiske betraktninger, er det antatt at en moderat massiv gruppe må anvendes ved acyler-inq slik at acylerinqen ved sterisk hindring fortrinnsvis skjer ved oxyqenerinq av C-l stillinq. Likeledes er det antatt at 0-al-kvlerinqen ved C-l favoriseres under basiske betinqelser, oq at størrelsen av den alkylerende qruppe er av mindre betydninq enn ved acylerinqen. I alle tilfeller ble det fvftmet at de ovenfor an-qitte betinqelser tillater bibeholdelse av det asymmetriske senter ved C-4, oq at der ikke skjer noen racematdannelse. Although one does not want to be bound by theoretical considerations, it is assumed that a moderately massive group must be used for acylation so that the acylation by steric hindrance preferably takes place by oxyqenerinq of C-1 stillinq. Likewise, it is assumed that the 0-al-quelation at C-1 is favored under basic conditions, and that the size of the alkylating group is of less importance than in the case of acylation. In all cases, it was found that the above-mentioned conditions allow retention of the asymmetric center at C-4, and that no racemate formation occurs.

Den asymmetriske reduksjon av 2-substituerte cyclopen-tan-l,3,4-trion til det tilsvarende 2-substituerte-4(R)-hydroxy-cyclopentan-l,3-dion utføres ved katalytisk hydroqenerinq i nærvær av et rhodiumkompleks med en kiral fosfinkjede (liqand) som katalysator. (Katalysatorer av denne type er beskrevet i Chem. Soc, Chem. Comm., 19, (1972) av W.S. Knowles et al.). Den foretrukne Katalysator ved denne fremgangsmåte kan betegnes som I^Rl^COD BF^~ The asymmetric reduction of 2-substituted cyclopentane-1,3,4-trione to the corresponding 2-substituted-4(R)-hydroxy-cyclopentane-1,3-dione is carried out by catalytic hydrogenation in the presence of a rhodium complex with a chiral phosphine chain (liqand) as catalyst. (Catalysts of this type are described in Chem. Soc, Chem. Comm., 19, (1972) by W.S. Knowles et al.). The preferred Catalyst in this method can be designated as I^Rl^COD BF^~

(tilgjengelig fra Monsanto Co., St.Louis, Mo., under typebeteg-nelsen CP71327), hvor L indikerer o-anisylcyclohexylmethylfosfin, og COD indikerer 1,5-cyclooctadien. (available from Monsanto Co., St.Louis, Mo., under the type designation CP71327), where L indicates o-anisylcyclohexylmethylphosphine, and COD indicates 1,5-cyclooctadiene.

En metode for hydrogenering av 2(6-carbomethoxyhexyl)-cyclopentan-l,3,4-trion under anvendelse av den foretrukne katalysator er angitt i det etterfølgende: Fremstilling av 2-(6-carbomethoxyhexyl)-4(R)-hydroxy-cyclopentan-1,3-dion 5,0 g 2(6-carbomethoxyhexyl)-cyclopentan-1,3,4-trion, 95,8 mg av den angitte katalysator og 2,78 ml triethylamin ble oppløst i 35 ml methanol og underkastet hydrogenering ved en at-mosfære. Efter at 92,6 % av den teoretiske mengde hydrogen var forbrukt, ble reaksjonen avsluttet ved at hydrogeneringsreaksjons-blandingen ble heldt over i HCl-I^O (ca. pH 2). Den resulterende blanding ble ekstrahert tre ganger med ethylacetat, de organiske lag ble fraskilt og vasket med natriumbicarbonatoppløsning (5 % oppløsning) inntil ingen farve var synlig i den vandige fase. De kombinerte bicarbonatekstrakter ble ekstrahert med ethylacetat, det resulterende gule vandige lag ble forsiktig surgjort til pH 2 med saltsyre og ekstrahert med ethylacetat. Det organiske lag ble fraskilt, tørket over Na2S0^ og fordampet til tørrhet. Det tørkede materiale ble oppløst i ethylacetat og derefter krystal-lisert fra dette, hvorved der ble erholdt 1,7 g produkt (34 % ut-bytte med følgende karakteristika: UV A JJ^°jj 272 nm ( £ 24 000), CDA281 nm, 6 = -58,3 x.IO<3>, 9 = A method for the hydrogenation of 2(6-carbomethoxyhexyl)-cyclopentane-1,3,4-trione using the preferred catalyst is set forth below: Preparation of 2-(6-carbomethoxyhexyl)-4(R)-hydroxy- cyclopentane-1,3-dione 5.0 g of 2(6-carbomethoxyhexyl)-cyclopentane-1,3,4-trione, 95.8 mg of the indicated catalyst and 2.78 ml of triethylamine were dissolved in 35 ml of methanol and subjected to hydrogenation at one atmosphere. After 92.6% of the theoretical amount of hydrogen had been consumed, the reaction was terminated by pouring the hydrogenation reaction mixture into HCl-I^O (approx. pH 2). The resulting mixture was extracted three times with ethyl acetate, the organic layers were separated and washed with sodium bicarbonate solution (5% solution) until no color was visible in the aqueous phase. The combined bicarbonate extracts were extracted with ethyl acetate, the resulting yellow aqueous layer was carefully acidified to pH 2 with hydrochloric acid and extracted with ethyl acetate. The organic layer was separated, dried over Na 2 SO 4 and evaporated to dryness. The dried material was dissolved in ethyl acetate and then crystallized from this, whereby 1.7 g of product was obtained (34% yield with the following characteristics: UV A JJ^°jj 272 nm ( £ 24,000), CDA 281 nm , 6 = -58.3 x.IO<3>, 9 =

+60 x IO<3> ved A 262 nm (68 % ootisk renhet). Svmbolet UV betea-ner ultrafiolett, og CD betegner sirkeldikroisme. En annen mengde (1,6 %) viste ingen optisk aktivitet, filtratet praktisk talt ingen optisk aktivitet. +60 x IO<3> at A 262 nm (68% otic purity). The symbol UV stands for ultraviolet, and CD stands for circular dichroism. Another amount (1.6%) showed no optical activity, the filtrate practically no optical activity.

Trionmethylesteren anvendt som utgangsmateriale ved den ovenfor angitte hydrogeneringsreaksjon kan lett erholdes fra den tilsvarende trionsyre ifølge følgende fremgangsmåte, trionsyren kan lett erholdes efter den av Pappo et al. angitte metode: The trione methyl ester used as starting material in the hydrogenation reaction indicated above can be easily obtained from the corresponding trionic acid according to the following method, the trionic acid can be easily obtained according to that of Pappo et al. set method:

En blanding av 1 g trionsyre, 2 ml methanol, 0,2 ml kon-sentrert HC1 og 2,5 ml dimethoxypropan fikk stå ved romtemperatur over natten. Oppløsningen ble derefter fordampet til tørrhet (rotasjonsfordamper), og residuet ble oppløst i 10 ml ethylacetat. Ethylacetatlaget ble eks trahert med en mettet NaHCO-^-oppløsning (2 x 15 ml). Bicarbonatoppløsningen ble surgjort og ekstrahert med ethylacetat (4 x 25 ml). Denne ekstrakt ble vasket med en mettet NaCl-oppløsning og tørket over MgS04. Fordampning av opp-løsningsmidlet ga en rødaktig olje som stivnet ved henstand under dannelse av et gult, fast materiale (tilsetning av en krystall av trionmethylesteren lettet stivningsprosessen). A mixture of 1 g of trionic acid, 2 ml of methanol, 0.2 ml of concentrated HCl and 2.5 ml of dimethoxypropane was allowed to stand at room temperature overnight. The solution was then evaporated to dryness (rotary evaporator), and the residue was dissolved in 10 ml of ethyl acetate. The ethyl acetate layer was extracted with a saturated NaHCO 3 solution (2 x 15 mL). The bicarbonate solution was acidified and extracted with ethyl acetate (4 x 25 mL). This extract was washed with a saturated NaCl solution and dried over MgSO 4 . Evaporation of the solvent gave a reddish oil which solidified on standing to form a yellow solid (addition of a crystal of the trione methyl ester facilitated the solidification process).

Alternativt kan dionet fremstilles mikrobiologisk, som beskrevet i norsk ålment tilgjengelig søknad 3795/73 med priori-tet fra 29.september 1972, ved å underkaste 2-substituert-cyclo-penten-1,3,4-trion eller 2-substituert-3-alkoxy-2-cyclopenten-1,4-dion en fermentativ enzymatisk virkning av en mikroorganisme av klassen Ascomycetes, eller via spaltning med brucin som senere angitt. 6 g, 0,022 mol, 2-(6 -carbomethoxyhexyl)-4-hydroxy-cyclo-pentan-1,3-dion ble blandet med 8,7 g, 0,022 mol, brucin. Til denne blanding ble det tilsatt 35 ml aceton og den resulterende løsning ble kokt under tilbakeløp og under nitrogenatmosfære i 15 minutter, kjølt til romtemperatur og fikk deretter stå ved romtemperatur i 3 timer og deretter i et kjøleskap (4 - 10° C) over natten. Produktet, et brucinhydroxydionsalt utskiltes som fine krystaller. Krystallene ble filtrert fra på en buchner-trakt, vasket med kald aceton og ble omkrystallisert til konstant optisk rotasjon fra ethylacetat og Skelly B (fem omkrystallisasjoner). Skelly B er n-hexan. Alternatively, the dione can be produced microbiologically, as described in Norwegian generally available application 3795/73 with priority from 29 September 1972, by subjecting 2-substituted-cyclo-pentene-1,3,4-trione or 2-substituted-3 -Alkoxy-2-cyclopentene-1,4-dione a fermentative enzymatic action of a microorganism of the class Ascomycetes, or via cleavage with brucine as indicated later. 6 g, 0.022 mol, 2-(6-carbomethoxyhexyl)-4-hydroxy-cyclo-pentane-1,3-dione was mixed with 8.7 g, 0.022 mol, brucine. To this mixture was added 35 ml of acetone and the resulting solution was refluxed under a nitrogen atmosphere for 15 minutes, cooled to room temperature and then allowed to stand at room temperature for 3 hours and then in a refrigerator (4 - 10°C) overnight . The product, a brucine hydroxydione salt is excreted as fine crystals. The crystals were filtered off on a buchner funnel, washed with cold acetone and recrystallized to constant optical rotation from ethyl acetate and Skelly B (five recrystallizations). Skelly B is n-hexane.

Optisk rotasjon av saltet i CHCI3: Optical rotation of the salt in CHCI3:

2,2 g av det spaltede brucin-hydroxydionsalt ble løst i 2.2 g of the cleaved brucine hydroxydione salt were dissolved in

30 ml ethylacetat. Til denne løsning ble 30 ml 0,25 N HC1 tilsatt og den heterogene blanding ble omrørt meget kraftig i 2 minutter. Ved henstand dannet det seg to lag som ble separart. Det vandige lag ble ekstrahert to ganger med ethylacetat. De organiske lag fra de to ekstraksjoner ble kombinert og ble vasket med vann og mettet saltvannløsning og ble, tørket over vannfritt magnesiumsulfat. Fordampning av løsningsmidlet ga 780 mg 2-(6<1->carbomethoxyhexyl)-4(R)-hydroxy-cyclopentan-1,3-dion som et hvitt fast krystallinsk stoff. 30 ml of ethyl acetate. To this solution was added 30 ml of 0.25 N HCl and the heterogeneous mixture was stirred very vigorously for 2 minutes. During the reprieve, two teams formed and were separated. The aqueous layer was extracted twice with ethyl acetate. The organic layers from the two extractions were combined and washed with water and saturated saline and dried over anhydrous magnesium sulfate. Evaporation of the solvent gave 780 mg of 2-(6<1->carbomethoxyhexyl)-4(R)-hydroxy-cyclopentane-1,3-dione as a white crystalline solid.

Som tidligere angitt kan enoliseringen av det 2-substituerte dion utføres for omdannelse til enolester eller enoletherkonfi-gurasjon gjennom selektiv O-acylering eller selektiv O-alkylering ifølge følgende generelle metode. As previously indicated, the enolization of the 2-substituted dione can be carried out for conversion to the enol ester or enol ether configuration through selective O-acylation or selective O-alkylation according to the following general method.

Enolisering med selektiv O- acylering Enolization with selective O-acylation

Generelt kan denne reaksjon utføres etter følgende skje-matiske reaksjonsskjema: In general, this reaction can be carried out according to the following schematic reaction scheme:

hvor R og R" har de tidligere angitte betydninger. where R and R" have the previously stated meanings.

Ved den angitte O-acyleringsreaksjon er det fordelaktig In the indicated O-acylation reaction, it is advantageous

å anvende bare én ekvivalent av acyleringsmidlet, da bruk av over-skudd av acyleringsmidler er tilbøyelig til også å aktivere acylering av hydroxylgruppen. Likeledes er acyleringsgruppens stør-relse viktig med hensyn til dannelse av den ønskede fenolester, to use only one equivalent of the acylating agent, as the use of excess acylating agents tends to also activate acylation of the hydroxyl group. Likewise, the size of the acylation group is important with regard to the formation of the desired phenolic ester,

en mer massiv gruppering aktiverer dannelsen av mer av den ønskede enolform, dvs. 0,acylering av C-l-stilling. Med acetylklorid som acyleringsmiddel, hvilket er kjent, og 2(6-carbomethoxyhexyl)-4(R)-hydroxy-2-cyclopentan-l,3-dion som substrat dannes f.eks. to enolacylater a more massive grouping activates the formation of more of the desired enol form, ie 0,acylation of the C-1 position. With acetyl chloride as acylating agent, which is known, and 2(6-carbomethoxyhexyl)-4(R)-hydroxy-2-cyclopentane-1,3-dione as substrate, e.g. two enolacylates

i et forhold på 70 - 75 % av A til 30 - 25 % av B. Når imidler-tid et mer passivt acyleringsmiddel slik som pivaloylklorid anvendes, er forholdet mellom det ønskede substituerte C-l-enol-pivaloylat og det substituerte C-3-enolpivaloylat ca. 90:10. in a ratio of 70 - 75% of A to 30 - 25% of B. However, when a more passive acylating agent such as pivaloyl chloride is used, the ratio between the desired substituted C-1-enol pivaloylate and the substituted C-3-enol pivaloylate is about. 90:10.

Enolisering med selektiv O- alkylering Enolization with selective O-alkylation

O-alkyleringsreaksjonen kan utføres efter følgende reaksjonsskjema: The O-alkylation reaction can be carried out according to the following reaction scheme:

hvor R og R<1> har de tidligere angitte betydninger. where R and R<1> have the previously stated meanings.

Som bemerket med hensyn til O-acyleringen influerer denne relative størrelse alkyleringsmidlet på forholdet mellom de dannede enolethere, dvs. forholdet mellom substituert C-l-enolether i forhold til substituert C-3-enolether. Med f.eks. isopropyljodid som alkyleringsmiddel og 2(6-carbomethoxyhexyl)-4(R)-hydroxy-2-cyclopentan-1,3-dion som substratet ble de to enolethere As noted with respect to the O-acylation, this relative size of the alkylating agent influences the ratio of the enol ethers formed, i.e. the ratio of substituted C-1 enol ether to substituted C-3 enol ether. With e.g. isopropyl iodide as the alkylating agent and 2(6-carbomethoxyhexyl)-4(R)-hydroxy-2-cyclopentane-1,3-dione as the substrate became the two enol ethers

dannet i et forhold mellom A og B på 6:4, mens når isoamyljodid, som er en større gruppering, ble anvendt som alkyleringsmiddel var forholdet mellom den ønskede substituerte C-l-enolether til den substituerte C-3-enolether ca. 7:3. formed in a ratio between A and B of 6:4, while when isoamyl iodide, which is a larger grouping, was used as alkylating agent, the ratio of the desired substituted C-1 enol ether to the substituted C-3 enol ether was approx. 7:3.

Den etterfølgende tabell angir de relative mengder av enoletherne erholdt med de angitte alkyleringsmidler: The following table indicates the relative amounts of the enol ethers obtained with the indicated alkylating agents:

Reduksjon av den substituerte C-l-enolester eller enolether kan lett utføres med natriumdihydro-bis-(2-methoxyethoxy)-aluminat (kaldt Red-Al middel) som vist av Pappo et al., Tetra-hedron Letters, No. 26, p. 2627 (1972), Pergamon Press. Andre reduksjonsmidler slik som f.eks. lithiumborhydrid, diisobutylalu-miniumhydrid og lithiumaluminiumhydrid er også istand til å redu-sere carbonyl-funksjonen av den substituerte C-l-enolester eller ether ifølge fremgangsmåten ifølge oppfinnelsen under dannelse av de ønskede 2-substituerte-4(R)-hydroxy-2-cyclopenten-l-on-pro-dukter. Reduction of the substituted C-1 enol ester or enol ether can be easily carried out with sodium dihydro-bis-(2-methoxyethoxy)-aluminate (cold Red-Al agent) as shown by Pappo et al., Tetra-hedron Letters, No. 26, p. 2627 (1972), Pergamon Press. Other reducing agents such as e.g. lithium borohydride, diisobutylaluminum hydride and lithium aluminum hydride are also able to reduce the carbonyl function of the substituted C-1-enol ester or ether according to the method according to the invention, forming the desired 2-substituted-4(R)-hydroxy-2-cyclopentene- l-on products.

De følgende eksempler illustrerer oppfinnelsen. The following examples illustrate the invention.

Eksempel. 1 Fremstilling av di- ertolbenzoater Example. 1 Production of di-ertol benzoates

Til en oppløsning av 120 mg (0,467 mmol) 2(6-carbometh-oxyhexyl) -4 (R) -hydroxy-cyclopentan-1, 3-dion (II), 0,4 ml (ca. 3 mmol) triethylamin (Et^N) (destillert over CaH2) i 10 ml tetrahydrofuran (THF) kjølt til -15°C ble tilsatt 0,5 ml (4,34 mmol) benzoylklorid i løpet av 5 minutter under omrøring. Efter at reaksjonsblandingen var omrørt ved -15 til 5°C i 3 timer, ble vann tilsatt, og blandingen ble ekstrahert tre ganger med diethylether. Etherlaget ble vasket henholdsvis med fortynnet HC1, vann, mettet NaHCO-j og NaCl-oppløsninger. Etherlaget ble derefter tørket over Na2S0^ og fordampet til tørrhet. Protonmagnetisk resonans (PMR) analyse viste at det tørkede produkt inneholde 90 % av det ønskede substituerte C-l-dibenzoat (Illa) som lett kunne separeres ved kolonnekromatografi ved bruk av siliciumsyre-Celite (85:15) ko-lonne (21 x 2,5 cm) med en benzen-ethylacetatgradient som beskrevet i eksempel 4. To a solution of 120 mg (0.467 mmol) 2(6-carbometh-oxyhexyl)-4 (R)-hydroxy-cyclopentane-1, 3-dione (II), 0.4 ml (ca. 3 mmol) triethylamine (Et ^N) (distilled over CaH2) in 10 ml of tetrahydrofuran (THF) cooled to -15°C was added 0.5 ml (4.34 mmol) of benzoyl chloride over 5 minutes with stirring. After the reaction mixture was stirred at -15 to 5°C for 3 hours, water was added, and the mixture was extracted three times with diethyl ether. The ether layer was washed respectively with dilute HCl, water, saturated NaHCO-j and NaCl solutions. The ether layer was then dried over Na 2 SO 4 and evaporated to dryness. Proton magnetic resonance (PMR) analysis showed that the dried product contained 90% of the desired substituted C-1-dibenzoate (IIa) which could be easily separated by column chromatography using a silicic acid-Celite (85:15) column (21 x 2.5 cm) with a benzene-ethyl acetate gradient as described in Example 4.

Eksempel 2 Fremstilling av mono- enolbenzoatesteren Example 2 Preparation of the monoenol benzoate ester

Til en avkjølt (-11° C) omrørt løsning av 102,4 mg (0,4 mmol) av hydroxydionmethylesteren (III) og 0,112 ml (ca. 0,84 mmol) triethylamin (destillert over kalsiumhydrid) i 8 ml tørr tetrahydrofuran (under ( ble tilsatt 0,046 ml (0,4 mmol) benzoylklorid i løpet av 5 minutter. Den resulterende løsning ble omrørt ved -10°C i 35 minutter. 4 ml methano.l ble tilsatt og løsningen ble oppvarmet til romtemperatur og ble deretter heldt over i 60 ml vann. Denne løsning ble ekstrahert fire ganger med 50 ml ethylacetat hver gang og de kombinerte ekstrakter ble vasket henholdsvis med 0,IN HC1 (10 ml), vann (10 ml), mettet natriumbicarbonat (10 ml) (natrium-bicarbonatvaskevannet ble surgjort og ekstrahert med ethylacetat. Ekstraktet ble vasket med mettet natriumkloridløsning og tørket over MgSO^. Fordampning av løsningsmidlet ga uomsatt hydroxydion-methylester (30 mg) II,) og mettet natriumklorid (10 ml) løsninger og tørket over MgSO^. Fordampning av løsningsmidlet ga en gul olje med følgende karakteristika: PMR 63,65 (S, 3H, OCH3, 64,48 (q, 1H, H-C-OH), 87,70 (m, 3H) og 68,18 (m, 2H) aromatiske protoner, m/e ved 360, (cx)q<4> + 35° (C, 2,0 CHCI3) , Xjj][£ s 241 nm (e 20.100), (S) 270 nm (e 8,500) hvilket identifiserte produktet som Hig. Eksempel 3 Fremstilling av isopropylenol- etheren Til 514 mg av hydroxydionesteren (II) (2,0 mmol), ble tilsatt 546 mg I^CO-j (4 mmol), og 5 ml (8,5 g, 50 mmol) isopropyljodid i 25 ml tørr aceton. Blandingen ble oppvarmet under tilbake-løpskjøling (N2-atmosfære) i 24 timer. Etter avkjøling ble reaksjonsblandingen fortynnet med Et20 og etherlaget ble vasket henholdsvis med vann, NaHCO^, vann og mettet NaCl. Løsningsmiddellaget ble deretter tørket over Na2S04 og fordampet til tørrhet hvorved det ble erholdt 560 mg av et oljeaktig residuum. Residuet ble løst i isopropylether hvorved det ble erholdt 316 mg (53 %) av et produkt med følgende karakteristika: sm.p. 60 - 62° C, A*^g 259 nm (e 20.600), PMR (CHC13) 1,35 (d, 6 „„ -""CH3 ), 63,65 (s, COOCH3) , 64,32 (q, 1, CHOH) , 4,67 (s, 1, CH^™3 ), m/e 298, (a)<* >+ 35,1 (C, 1,02 MeOH), hvilket identifiserte 3 det som Illh. Eksempel <4 >Fremstilling av isoamylenoletheren To a cooled (-11° C) stirred solution of 102.4 mg (0.4 mmol) of the hydroxydione methyl ester (III) and 0.112 ml (ca. 0.84 mmol) of triethylamine (distilled over calcium hydride) in 8 ml of dry tetrahydrofuran ( under (0.046 mL (0.4 mmol) of benzoyl chloride was added over 5 minutes. The resulting solution was stirred at -10°C for 35 minutes. 4 mL of methanol was added and the solution was warmed to room temperature and then poured into 60 mL of water. This solution was extracted four times with 50 mL of ethyl acetate each time and the combined extracts were washed respectively with 0.1N HCl (10 mL), water (10 mL), saturated sodium bicarbonate (10 mL) (sodium The bicarbonate wash was acidified and extracted with ethyl acetate. The extract was washed with saturated sodium chloride solution and dried over MgSO^. Evaporation of the solvent gave unreacted hydroxydione methyl ester (30 mg) II,) and saturated sodium chloride (10 mL) solutions and dried over MgSO^. Evaporation of the solvent gave a yellow oil of the following character ristika: PMR 63.65 (S, 3H, OCH3, 64.48 (q, 1H, H-C-OH), 87.70 (m, 3H) and 68.18 (m, 2H) aromatic protons, m/e at 360, (cx)q<4> + 35° (C, 2.0 CHCl 3 ), Xjj][£ s 241 nm (e 20,100), (S) 270 nm (e 8,500) which identified the product as Hig. Example 3 Preparation of the isopropylenol ether To 514 mg of the hydroxydionester (II) (2.0 mmol), 546 mg of I^CO-j (4 mmol) and 5 ml (8.5 g, 50 mmol) of isopropyl iodide in 25 ml of dry acetone. The mixture was heated under reflux (N2 atmosphere) for 24 hours. After cooling, the reaction mixture was diluted with Et 2 O and the ether layer was washed respectively with water, NaHCO 3 , water and saturated NaCl. The solvent layer was then dried over Na 2 SO 4 and evaporated to dryness to give 560 mg of an oily residue. The residue was dissolved in isopropyl ether whereby 316 mg (53%) of a product with the following characteristics was obtained: m.p. 60 - 62° C, A*^g 259 nm (e 20,600), PMR (CHC13) 1.35 (d, 6 „„ -""CH3 ), 63.65 (s, COOCH3) , 64.32 (q , 1, CHOH) , 4.67 (s, 1, CH^™3 ), m/e 298, (a)<* >+ 35.1 (C, 1.02 MeOH), which identified 3 it as Illh . Example <4 >Preparation of the isoamylenol ether

Til 121 mg II, 287 mg K2CC>3 i 15 ml tørr aceton ble tilsatt 2 ml isoamyljodid. Etter tilbakeløp over natten ble reaksjonsblandingen opparbeidet som beskrevet i eksempel 5. Det ble erholdt 165 mg residuum. PMR-analyse viste en isopropyldublett (60,95 J = 6HZ), kompleks region (61,1 - 3,1), methoxyl (63,65), multiplett ( y^ 64,0 - 4,5, ca. 3H basert på methoxyl) og en bred dublett (65,0, J = 6) To 121 mg of II, 287 mg of K2CC>3 in 15 ml of dry acetone was added 2 ml of isoamyl iodide. After refluxing overnight, the reaction mixture was worked up as described in example 5. 165 mg of residue was obtained. PMR analysis showed an isopropyl doublet (60.95 J = 6HZ), complex region (61.1 - 3.1), methoxyl (63.65), multiplet ( γ^ 64.0 - 4.5, ca. 3H based on methoxyl) and a broad doublet (65.0, J = 6)

(30 % 1H, basert på methoxyl), ca. 4H total integral fra 64,0 til 65,10 indikerte innbefattelse av -OH, -OCH2-CH2-CH2CHMe2 og OH-CH. Således ble produktet beregnet å inneholde ca. 70 % av den ønskede substituerte C-l enolether Uli, som lett ble fraskilt fra den substituerte C-3 enolether ved kolonnekromatografi som beskrevet i eksempel 4. (30% 1H, based on methoxyl), approx. 4H total integral from 64.0 to 65.10 indicated inclusion of -OH, -OCH2-CH2-CH2CHMe2 and OH-CH. Thus, the product was calculated to contain approx. 70% of the desired substituted C-1 enol ether Uli, which was easily separated from the substituted C-3 enol ether by column chromatography as described in Example 4.

Eksempel 5 5 Example 5 5

Reduksjon av mono- enolbenzoatesteren med " Red- Al" Reduction of the mono-enol benzoate ester with "Red-Al"

Til en kjølt (-78° C), omrørt løsning av 50 mg (0,147 To a chilled (-78° C), stirred solution of 50 mg (0.147

mmol) mono-enolbenzoat (Hig) i 10 ml tørr tetrahydrofuran under N2» ble "Red-Al" løsning (1,5 M i toluen) tilsatt i fire 0,38 ml porsjo-ner i løpet av 15 minutter. Den resulterende løsning ble omrørt ved mmol) of mono-enol benzoate (Hig) in 10 ml of dry tetrahydrofuran under N 2 , "Red-Al" solution (1.5 M in toluene) was added in four 0.38 ml portions over 15 minutes. The resulting solution was stirred at

-78° C i ytterligere 30 minutter. 2 ml iseddik ble tilsatt og løs-ningen fikk oppvarmes til romtemperatur. Løsningen ble heldt over i 40 ml vann og ekstrahert med ethylacetat (4 x 30 ml). Ethylacetatlaget ble vasket med 10 ml hver av mettet natriumbicarbonat og mettet NaCl-løsninger og tørket over MgSO^. Fordampning av en olje. Oljen ble løst i 10 ml eddiksyre-vann (75:25) løsning. Den resulterende løsning ble omrørt ved romtemperatur i 24 timer. Eddiksyre vann ble fordampet fra under redusert trykk. Den resulterende olje ble løst i ethylacetat (10 ml) og vasket med mettet natriumbicarbo-natløsning og mettet natriumkloridløsning og tørket over MgS04. Fordampning av løsningsmidlet ga en gul olje (ca. 25 - 30 mg). Kry-stallisasjon fra ethylacetat-Skelly B ga 20 mg IV, som ble identifisert ved følgende karakteristika: sm.p. 60 - 61° C, (ci)q<4> = -78° C for a further 30 minutes. 2 ml of glacial acetic acid was added and the solution was allowed to warm to room temperature. The solution was poured into 40 ml of water and extracted with ethyl acetate (4 x 30 ml). The ethyl acetate layer was washed with 10 ml each of saturated sodium bicarbonate and saturated NaCl solutions and dried over MgSO 4 . Evaporation of an oil. The oil was dissolved in 10 ml of acetic acid-water (75:25) solution. The resulting solution was stirred at room temperature for 24 hours. Acetic water was evaporated from under reduced pressure. The resulting oil was dissolved in ethyl acetate (10 mL) and washed with saturated sodium bicarbonate solution and saturated sodium chloride solution and dried over MgSO 4 . Evaporation of the solvent gave a yellow oil (ca. 25 - 30 mg). Crystallization from ethyl acetate-Skelly B gave 20 mg of IV, which was identified by the following characteristics: m.p. 60 - 61° C, (c1)q<4> =

17,82° (C, 0,49 MeOH), PMR (CDCII3) 63,65 (s, 3, COOCH3), 64,93 (m, 1, H-C-OH) , 67,23 (m, 1, vinyl H) , UV xjjj£]j 222 nm (e 8 400) CD 231 nm 9 -9,9° x IO<-3> (MeOH). 17.82° (C, 0.49 MeOH), PMR (CDCII 3 ) 63.65 (s, 3, COOCH 3 ), 64.93 (m, 1, H-C-OH) , 67.23 (m, 1, vinyl H) , UV xjjj£]j 222 nm (e 8 400) CD 231 nm 9 -9.9° x 10<-3> (MeOH).

Eksempel 6 Example 6

Reduksjon av isopropylrénoletheren med Red- Al Reduction of the isopropyl renol ether with Red-Al

De 123 mg av isopropylenoletheren (Illh) (0,412 mmol) i The 123 mg of the isopropylenol ether (Illh) (0.412 mmol) i

10 ml THF, rørt under nitrogen ved -78° C, ble fire 1,1 ml's por-sjoner av en løsning av Red-Al i benzen (1,5 M) dråpevis tilsatt i løpet av 7 minutter. Reaksjonsblandingen ble omrørt ved -78° C i 45 minutter og 2 ml eddiksyre ble deretter tilsatt. Reaksjonsblandingen fikk oppvarmes til romtemperatur og ble fordampet til tørr-het. 10 ml 75 %-ig eddiksyreløsning ble tilsatt og rørt i 24 timer. Eddiksyre og vannet ble fordampet fra under trykk. Den resulterende olje ble løst i 25 ml ethylacetat og vasket med mettet NaHC03 og NaCl-løsninger og deretter tørket over .magnesiumsulfat. Krystalli-sasjon av residuet fra ethylacetat-Skelly B ga 60 mg IV, som ble identifisert ved følgende karakteristika: sm.p. 60 - 61° C, (a)D To 10 ml of THF, stirred under nitrogen at -78°C, four 1.1 ml portions of a solution of Red-Al in benzene (1.5 M) were added dropwise over 7 minutes. The reaction mixture was stirred at -78°C for 45 minutes and 2 ml of acetic acid was then added. The reaction mixture was allowed to warm to room temperature and was evaporated to dryness. 10 ml of 75% acetic acid solution was added and stirred for 24 hours. Acetic acid and water were evaporated from under pressure. The resulting oil was dissolved in 25 ml of ethyl acetate and washed with saturated NaHCO 3 and NaCl solutions and then dried over magnesium sulfate. Crystallization of the residue from ethyl acetate-Skelly B gave 60 mg of IV, which was identified by the following characteristics: m.p. 60 - 61° C, (a)D

+ 17,82° (C, 0,49 MeOH) , UV .xjjjj 222 nm (e 8.400) , CD 231 nm 9.= -9,9° x 10~<3> (MeOH). + 17.82° (C, 0.49 MeOH) , UV .xjjjj 222 nm (e 8,400) , CD 231 nm 9.= -9.9° x 10~<3> (MeOH).

Omdannelsen av forbindelsene fremstilt ifølge fremgangsmåten, nemlig., 2-(6-carbalkoxyhexyl)-4 (Rl-hydroxy-cyclopent-2-enoner til prostaglandiner eller prostaglandin-lignende forbindelser kan utfø-res etter fremgangsmåten beskrevet av Charles J. Sih et al. (J.Amer. Chem. Soc, 94' 3643 (mai 17,nde, 1972)). Såsnart den ovenfor stereospesifike forbindelse er erholdt kan omdannelsen til prostaglandiner eller prostaglandin-lignende forbindelser lett utføres med bibeholdelse av den ønskede stereokjemi. The conversion of the compounds prepared according to the method, namely, 2-(6-carbalkoxyhexyl)-4-(R1-hydroxy-cyclopent-2-enones) to prostaglandins or prostaglandin-like compounds can be carried out according to the method described by Charles J. Sih et al .(J.Amer. Chem. Soc, 94' 3643 (May 17th, 1972)) Once the above stereospecific compound is obtained, the conversion to prostaglandins or prostaglandin-like compounds can be easily accomplished while retaining the desired stereochemistry.

I tillegg til å kunne anvendes som et utgangsmateriale ved fremstilling av prostaglandiner, ble l-isopropoxy-2-(6'-carbo-methoxyhexyl) -4(R)-hydroxy-l-cyclopenten-3-on (isopropylenoletheren) funnet å ha antimikrobiell aktivitet som vist i det følgende eksempel. In addition to being able to be used as a starting material in the production of prostaglandins, l-isopropoxy-2-(6'-carbo-methoxyhexyl)-4(R)-hydroxy-l-cyclopenten-3-one (isopropylenol ether) was found to have antimicrobial activity as shown in the following example.

Eksempel 7 Example 7

25 mg l-isopropoxy-2-(6'-carbomethoxyhexyl)-4(R)-hydroxy-l-cyclopenten-3-on ble løst i 1 ml methylalkohol. , 0,1 ml av den resulterende løsning ble påført en filterpapirskive (12,7 mmol) og skiven ble deretter tørket. Hver av de tørkede skiver ble deretter plassert i en petrlskål inneholdende 10 ml antibiotica medium II (Difco) til hvilket det var tilsatt 0,03 ml av et podestoff av test-organismen. Petriskålene ble incubert ved 25° C i 48 timer og inhi-beringssonen ble målt med følgende resultater: 25 mg of 1-isopropoxy-2-(6'-carbomethoxyhexyl)-4(R)-hydroxy-1-cyclopenten-3-one was dissolved in 1 ml of methyl alcohol. , 0.1 ml of the resulting solution was applied to a filter paper disc (12.7 mmol) and the disc was then dried. Each of the dried slices was then placed in a petri dish containing 10 ml of antibiotica medium II (Difco) to which was added 0.03 ml of an inoculum of the test organism. The Petri dishes were incubated at 25°C for 48 hours and the zone of inhibition was measured with the following results:

Claims (1)

Fremgangsmåte ved fremstilling av 2-(6-carbalkoxy-Procedure for the preparation of 2-(6-carbalkoxy- hexyl)-4(R)-hydroxy-cyclopent-2-enon av formelenhexyl)-4(R)-hydroxy-cyclopent-2-enone of the formula hvori R er en alkylgruppe med 1-2 carbonatomer, karakterisert ved at a) et 2-(6-carbalkoxyhexyl)-4(R)-hydroxycyclopentan-1,3-dion av formelen:in which R is an alkyl group with 1-2 carbon atoms, characterized in that a) a 2-(6-carbalkoxyhexyl)-4(R)-hydroxycyclopentane-1,3-dione of the formula: omsettes med et alkyliodid av formelen: R'Iis reacted with an alkyl iodide of the formula: R'I hvori R' er en isoamyl, isopropyl, isobutyl eller pivalylgruppe, under dannelse av en C-l og en C-3 enolether av formlene:wherein R' is an isoamyl, isopropyl, isobutyl or pivalyl group, forming a C-1 and a C-3 enol ether of the formulas: eller med benzoylklorid under dannelse av en C-l og C-3 enolester av formlene: hvor R" er fenyl, _b) C-l enoletheren henholdsvis esteren separeres fra C-3 enoletheren- eller esteren, c) den fremstillede C-l substituerte enolester eller ether reduseres, og d) 2-(6-carbalkoxyhexyl)-4(R)-hydroxycyclopent-2-enon utvinnes fra reaksjonsblandingen.or with benzoyl chloride to form a C-1 and C-3 enol ester of the formulas: where R" is phenyl, _b) the C-1 enol ether or ester is separated from the C-3 enol ether or ester, c) the produced C-1 substituted enol ester or ether is reduced, and d) 2-(6-carbalkoxyhexyl)-4(R)-hydroxycyclopent-2-enone is recovered from the reaction mixture.
NO734495A 1972-11-27 1973-11-26 PROCEDURES FOR THE PREPARATION OF 2- (6-CARBALCOXYHEXYL) -4 (R) -HYDROXYCYCLOPENT-2 ENONES NO138905C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30976672A 1972-11-27 1972-11-27

Publications (2)

Publication Number Publication Date
NO138905B true NO138905B (en) 1978-08-28
NO138905C NO138905C (en) 1978-12-06

Family

ID=23199601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO734495A NO138905C (en) 1972-11-27 1973-11-26 PROCEDURES FOR THE PREPARATION OF 2- (6-CARBALCOXYHEXYL) -4 (R) -HYDROXYCYCLOPENT-2 ENONES

Country Status (25)

Country Link
JP (1) JPS5328908B2 (en)
AR (1) AR198543A1 (en)
AT (1) AT330143B (en)
AU (1) AU459800B2 (en)
BE (1) BE807825A (en)
BG (1) BG21204A3 (en)
CA (1) CA1034139A (en)
CH (1) CH599098A5 (en)
CS (1) CS170480B2 (en)
DD (1) DD108516A5 (en)
DE (1) DE2358781C3 (en)
ES (1) ES420855A1 (en)
FR (1) FR2207905B1 (en)
GB (1) GB1440108A (en)
HU (1) HU169638B (en)
IE (1) IE38497B1 (en)
IL (1) IL43597A (en)
NL (1) NL7316147A (en)
NO (1) NO138905C (en)
PH (1) PH10276A (en)
PL (1) PL91162B1 (en)
RO (1) RO63011A (en)
SE (1) SE406462B (en)
SU (1) SU617005A3 (en)
ZA (1) ZA738581B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU529883B2 (en) * 1978-09-04 1983-06-23 Australian National University, The Substituted cyclopentenones
JPS56159683U (en) * 1980-04-28 1981-11-28
JP2696933B2 (en) * 1987-06-16 1998-01-14 日産化学工業株式会社 Substituted cyclic ketones and substituted cyclic enones and methods for their preparation
US5254708A (en) * 1987-06-16 1993-10-19 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US5231208A (en) * 1987-06-16 1993-07-27 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US5227505A (en) * 1987-06-16 1993-07-13 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same

Also Published As

Publication number Publication date
IL43597A (en) 1976-09-30
ES420855A1 (en) 1976-04-01
ZA738581B (en) 1974-09-25
DE2358781B2 (en) 1979-01-25
JPS4982649A (en) 1974-08-08
JPS5328908B2 (en) 1978-08-17
AU459800B2 (en) 1975-04-10
CA1034139A (en) 1978-07-04
ATA980073A (en) 1975-09-15
BG21204A3 (en) 1976-03-20
RO63011A (en) 1978-05-15
DD108516A5 (en) 1974-09-20
IE38497L (en) 1974-05-27
CS170480B2 (en) 1976-08-27
HU169638B (en) 1976-12-28
AR198543A1 (en) 1974-06-28
GB1440108A (en) 1976-06-23
PH10276A (en) 1976-11-03
NL7316147A (en) 1974-05-29
AT330143B (en) 1976-06-10
FR2207905A1 (en) 1974-06-21
SE406462B (en) 1979-02-12
BE807825A (en) 1974-03-15
DE2358781A1 (en) 1974-06-12
CH599098A5 (en) 1978-05-12
IL43597A0 (en) 1974-03-14
SU617005A3 (en) 1978-07-25
AU6228373A (en) 1975-04-10
PL91162B1 (en) 1977-02-28
NO138905C (en) 1978-12-06
IE38497B1 (en) 1978-03-29
FR2207905B1 (en) 1978-02-24
DE2358781C3 (en) 1979-11-08

Similar Documents

Publication Publication Date Title
Taber et al. Rhodium-mediated cyclopentane construction can compete with. beta.-hydride elimination: synthesis of (.+-.)-tochuinyl acetate
Bruckner The synthesis of gama-alkylidenebutenolides
BG97471A (en) Process for the preparation of 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2ó esters
FR2553774A1 (en) INTERPHENYLENE ANALOGUES OF 7-OXABICYCLOHEPTANE SUBSTITUTED PROSTAGLANDINS, IN PARTICULAR USEFUL AS CARDIOVASCULAR AGENTS
Cason et al. Branched-chain fatty acids. II. Syntheses in the C19 and C25 series. Preparation of keto esters
SATO et al. Mevalonolactone derivatives as inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase
FR2553773A1 (en) 7-OXABICYCLO-SUBSTITUTED PROSTAGLANDINE-PHENYLALCANOIC ACID DERIVATIVES, IN PARTICULAR USEFUL AS CARDIOVASCULAR AGENTS AND MEDICAMENTS CONTAINING THEM
NO138905B (en) PROCEDURES FOR THE PREPARATION OF 2- (6-CARBALCOXYHEXYL) -4 (R) -HYDROXYCYCLOPENT-2 ENONES
US5780675A (en) Deoxygossylic compounds
TWI710550B (en) Process for the preparation of lubiprostone and intermediates thereof
Sato et al. New Synthesis of the Both Enantiomers of (Z)-5-(l-Decenyl)-oxacyclopentan-2-one, the Pheromone of the Japanese Beetle
US3968141A (en) Processes for stereospecifically preparing chiral 2-substituted-4-hydroxy-2-cyclopenten-1-one
US2748160A (en) Process for preparing 2, 5-diacetoxysty-rene and intermediates therefor
US4057851A (en) Chiral 2-substituted-4-hydroxy-2-cyclopenten-1-one
US4873363A (en) Process for the preparation of 3-(4&#39;-bromobiphenyl-4-yl)tetralin-1-one
US4233129A (en) Process of preparation of alkyl esters of dl cis chrysanthemic acid
Marx et al. Synthesis of dihydroarbiglovin and stereochemistry of arbiglovin
JPS60208942A (en) Manufacture of optically active alpha-arylalkanoic acid
CN111087357A (en) Preparation method of Prisamod
CN114195640B (en) Synthesis process of hydroxytyrosol and intermediate thereof
Hauser et al. Synthesis and resolution of 2-hydroxyheptanoic acid
US4410721A (en) Process for the preparation of cyclopropene intermediates
Morisawa et al. Modification at the 5-Position of 4-Deoxypyridoxol and α4-Norpyridoxol
US3031512A (en) Unsaturated aliphatic alcohols
Rico et al. Novel stereocontrolled synthesis of the tricyclic lactone (1R, 3R, 6R, 9S)-6, 9-dimethyl-8-oxo-7-oxatricyclo [4.3. 0.03, 9] nonane